Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies

Alice B. Gottlieb; Robert E. Kalb; Richard G. Langley; Gerald G. Krueger; Elke M.G.J. De Jong; Lynn Guenther; Kavitha Goyal; Steven Fakharzadeh; Marc Chevrier; Stephen Calabro; Wayne Langholff; Alan Menter

Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies

Alice B. Gottlieb, Robert E. Kalb, Richard G. Langley, Gerald G. Krueger, Elke M.G.J. De Jong, Lynn Guenther, Kavitha Goyal, Steven Fakharzadeh, Marc Chevrier, Stephen Calabro, Wayne Langholff, Alan Menter

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

85 Citations (Scopus)

Original language	English
Pages (from-to)	1441-1448
Number of pages	8
Journal	Journal of Drugs in Dermatology
Volume	13
Issue number	12
Publication status	Published - Dec 1 2014

ASJC Scopus Subject Areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Gottlieb, A. B., Kalb, R. E., Langley, R. G., Krueger, G. G., De Jong, E. M. G. J., Guenther, L., Goyal, K., Fakharzadeh, S., Chevrier, M., Calabro, S., Langholff, W., & Menter, A. (2014). Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies. Journal of Drugs in Dermatology, 13(12), 1441-1448.

Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies. / Gottlieb, Alice B.; Kalb, Robert E.; Langley, Richard G. et al.
In: Journal of Drugs in Dermatology, Vol. 13, No. 12, 01.12.2014, p. 1441-1448.

Research output: Contribution to journal › Article › peer-review

Gottlieb, AB, Kalb, RE, Langley, RG, Krueger, GG, De Jong, EMGJ, Guenther, L, Goyal, K, Fakharzadeh, S, Chevrier, M, Calabro, S, Langholff, W & Menter, A 2014, 'Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies', Journal of Drugs in Dermatology, vol. 13, no. 12, pp. 1441-1448.

@article{41f5e33a7c0b44179181a47ea24a9c7d,

title = "Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies",

author = "Gottlieb, {Alice B.} and Kalb, {Robert E.} and Langley, {Richard G.} and Krueger, {Gerald G.} and {De Jong}, {Elke M.G.J.} and Lynn Guenther and Kavitha Goyal and Steven Fakharzadeh and Marc Chevrier and Stephen Calabro and Wayne Langholff and Alan Menter",

note = "Publisher Copyright: COPYRIGHT {\textcopyright} 2014",

year = "2014",

month = dec,

day = "1",

language = "English",

volume = "13",

pages = "1441--1448",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "12",

}

TY - JOUR

T1 - Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR)

T2 - Experience with infliximab and other systemic and biologic therapies

AU - Gottlieb, Alice B.

AU - Kalb, Robert E.

AU - Langley, Richard G.

AU - Krueger, Gerald G.

AU - De Jong, Elke M.G.J.

AU - Guenther, Lynn

AU - Goyal, Kavitha

AU - Fakharzadeh, Steven

AU - Chevrier, Marc

AU - Calabro, Stephen

AU - Langholff, Wayne

AU - Menter, Alan

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84920873215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920873215&partnerID=8YFLogxK

M3 - Article

C2 - 25607786

AN - SCOPUS:84920873215

SN - 1545-9616

VL - 13

SP - 1441

EP - 1448

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 12

ER -

Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies

ASJC Scopus Subject Areas

UN SDGs

Other files and links

Fingerprint

Cite this